Cardiopulmonary effects of antimalarial drugs: I. 4-Aminoquinolines: Chloroquine quinetholate
- 31 July 1970
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 17 (1) , 107-117
- https://doi.org/10.1016/0041-008x(70)90136-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pharmacological significance of biogenic amines in the lungs: 5‐hydroxytryptamineBritish Journal of Pharmacology, 1970
- Comparative toxicity of chloroquine and bis[(chloro-7″-quinolyl-4″)-amino-2′ propyl]-1,4-piperazine (WR 3863)Toxicology and Applied Pharmacology, 1969
- Pathologic physiology and chemotherapy of Plasmodium berghei: VII. Electrocardiogram in mice treated with quinidine and guanidines (ICI 3349 and WR 81,844)Experimental Parasitology, 1969
- Comparative toxicity of chloroguanide and nitroguanilToxicology and Applied Pharmacology, 1968
- Inhibition of histamine methylation by antimalarial drugsBiochemical Pharmacology, 1965
- Estimation of dopamine, noradrenaline, adrenaline and 5-hydroxytryptamine from single rat brainsJournal of Pharmacy and Pharmacology, 1965
- Chloroquine in Bronchial AsthmaJournal of Pharmacy and Pharmacology, 1963
- Quinoline Therapy in AsthmaSouthern Medical Journal, 1955